Taxonomic value of foliar characters in Dahlstedtia Malme: Leguminosae, Papilionoideae, Millettieae

Dahlstedtia Malme (Leguminosae) is a neotropical genus, native to the Brazilian Atlantic Forest, and comprises two species, D. pinnata (Benth.) Malme and D. pentaphylla (Taub.) Burk., although it has been considered a monotypic genus by some authors. Leaf anatomy was compared to verify the presence of anatomical characters to help delimit species. Foliar primordium, leaflet, petiolule, petiole and pulvinus were collected from cultivated plants (Campinas, SP, Brazil) and from natural populations (Picinguaba, Ubatuba and Caraguatatuba, SP, Brazil - D. pinnata; Antonina, PR, Brazil - D. pentaphylla). Studies on leaflet surface assessment (Scanning Electron Microscopy), as well as histology and venation analyses were carried out of dehydrated, fresh and fixed material from two species. Leaflet material was macerated for stomatal counts. Histological sections, obtained by free-hand cut or microtome, were stained with Toluidine Blue, Safranin/Alcian Blue, Ferric Chloride, Acid Phloroglucin. Secretory cavities are present in the lamina, petiolule, petiole, pulvinus and leaf primordium in D. pentaphylla, but not in D. pinnata, and can be considered an important character for species diagnosis. Other leaf characters were uninformative in delimiting Dahlstedtia species. There is cambial activity in the petiolule, petiole and pulvinus. This study, associated with other available data, supports the recognition of two species in Dahlstedtia.

Influência das características das substâncias húmicas aquáticas na eficiência da coagulação com o cloreto férrico

The aim of this study was to verify the influence of the apparent molecular size of aquatic humic substances on the effectiveness of coagulation with ferric chloride. Coagulation-filtration tests using jar test and bench-scale sand filters were carried out on samples of water with true color of approximately 100 Hazen units, prepared with aquatic humic substances of different molecular sizes (F1: < 0.45 µm, F2: 100 kDa - 0.45 µm, F3: 30 - 100 kDa and F4': < 30 kDa). For the water samples with lower apparent molecular size fractions, greater dosages of coagulant was needed to remove the color around 5.0 Hanzen units, mainly because these water samples contain higher concentrations of fulvic acids, which exhibited a larger number of negatively-charged groups.

Optimização do tratamento de um efluente aquoso resultante da utilização de cola nas máquinas de produção de placas de madeira

O presente trabalho teve como principais objectivos, estudar e optimizar o processo de tratamento do efluente proveniente das máquinas da unidade Cold-press da linha de produção da Empresa Swedwood, caracterizar a solução límpida obtida no tratamento e estudar a sua integração no processo, e por fim caracterizar o resíduo de pasta de cola obtido no tratamento e estudar a possível valorização energética deste resíduo. Após caracterização inicial do efluente e de acordo com os resultados de um estudo prévio solicitado pela Empresa Swedwood a uma empresa externa, decidiu-se iniciar o estudo de tratabilidade do efluente pelo processo físico-químico a coagulação/floculação. No processo de coagulação/floculação estudou-se a aplicabilidade, através de ensaios Jar-test, dos diferentes agentes de coagulação/floculação: a soda cáustica, a cal, o cloreto férrico e o sulfato de alumínio. Os melhores resultados neste processo foram obtidos com a adição de uma dose de cal de 500 mg/Lefluente, seguida da adição de 400 mg/Lefluente de sulfato de alumínio. Contudo, após este tratamento o clarificado obtido não possuía as características necessárias para a sua reintrodução no processo fabril nem para a sua descarga em meio hídrico. Deste modo procedeu-se ao estudo de tratamentos complementares. Nesta segunda fases de estudo testaram-se os seguintes os tratamentos: a oxidação química por Reagente de Fenton, o tratamento biológico por SBR (sequencing batch reactor) e o leito percolador. Da análise dos resultados obtidos nos diferentes tratamentos conclui-se que o tratamento mais eficaz foi o tratamento biológico por SBR com adição de carvão activado. Prevê-se que no final do processo de tratamento o clarificado obtido possa ser descarregado em meio hídrico ou reintroduzido no processo. Como o estudo apenas foi desenvolvido à escala laboratorial, seria útil poder validar os resultados numa escala piloto antes da sua implementação industrial. A partir dos resultados do estudo experimental, procedeu-se ao dimensionamento de uma unidade de tratamento físico-químico e biológico à escala industrial para o tratamento de 20 m3 de efluente produzido na fábrica, numa semana. Dimensionou-se ainda a unidade (leito de secagem) para tratamento das lamas produzidas. Na unidade de tratamento físico-químico (coagulação/floculação) os decantadores estáticos devem possuir o volume útil de 4,8 m3. Sendo necessários semanalmente 36 L da suspensão de cal (Neutrolac 300) e 12,3 L da solução de sulfato de alumínio a 8,3%. Os tanques de armazenamento destes compostos devem possuir 43,2 litros e 96 litros, respectivamente. Nesta unidade estimou-se que são produzidos diariamente 1,4 m3 de lamas. Na unidade de tratamento biológico o reactor biológico deve possuir um volume útil de 6 m3. Para que este processo seja eficaz é necessário fornecer diariamente 2,1 kg de oxigénio. Estima-se que neste processo será necessário efectuar a purga de 325 litros de lamas semanalmente. No final da purga repõe-se o carvão activado, que poderá ser arrastado juntamente com as lamas, adicionando-se 100 mg de carvão por litro de licor misto. De acordo com o volume de lamas produzidos em ambos os tratamentos a área mínima necessária para o leito de secagem é de cerca de 27 m2. A análise económica efectuada mostra que a aquisição do equipamento tem o custo de 22.079,50 euros, o custo dos reagentes necessários neste processo para um ano de funcionamento tem um custo total de 508,50 euros e as necessidades energéticas de 2.008,45 euros.

Chlorella sp. coagulation‐flocculation by inducing a modification on the pH broth medium

Dissertação apresentada à Faculdade de Ciências e Tecnologia da Universidade Nova de Lisboa para a obtenção do grau de Mestre em Bioenergia

Preparação de carvão ativado em baixas temperaturas de carbonização a partir de rejeitos de café: utilização de FeCl3 como agente ativante

Ferric chloride as a new activating agent was used to obtain activated carbons from agroindustrial waste. This material was prepared at three temperatures of pyrolysis, 200, 280 and 400 ºC. The carbonaceous materials obtained after the activation processes showed high specific surface areas (BET), with values higher than 900 m² g-1. The materials showed different behaviors in the adsorption of methylene blue dye and reactive red textile dye in water solutions. An important fact in the use of FeCl3 as an activating agent is that the activation temperature is at 280 ºC, well below of those commonly employed in chemical or physical activations described in the literature.

Influência das características das substâncias húmicas aquáticas na eficiência da coagulação com o cloreto férrico

The aim of this study was to verify the influence of the apparent molecular size of aquatic humic substances on the effectiveness of coagulation with ferric chloride. Coagulation-filtration tests using jar test and bench-scale sand filters were carried out on samples of water with true color of approximately 100 Hazen units, prepared with aquatic humic substances of different molecular sizes (F1: < 0.45 µm, F2: 100 kDa - 0.45 µm, F3: 30 - 100 kDa and F4': < 30 kDa). For the water samples with lower apparent molecular size fractions, greater dosages of coagulant was needed to remove the color around 5.0 Hanzen units, mainly because these water samples contain higher concentrations of fulvic acids, which exhibited a larger number of negatively-charged groups.

Histochemistry and morphoanatomy study on guava fruit during ripening

Guava (Psidium guajava L.) is a highly perishable fruit due to its intense metabolism during ripening. Information on the enzyme activities that degrade pectic substances, as well as the amount of pectin, is very contradictory and not clearly defined. Thus, this study aimed to monitor the changes occurred in the fruit during ripening through histochemical, physical, and scanning microscopy processes. Guavas were picked at the half-mature stage and stored for 9 days at 22 ± 1 °C and 78 ± 1% RH. The analyses conducted on the day of harvest (0) and each day of storage (1, 2, 3, 4, 5, 6, 7, and 8 days) were: firmness and histochemical analyses (ferric chloride, lugol, comassie blue, vanillin hydrochloric, and ruthenium red) observed under an optic microscope and a scanning electron microscope. Ruthenium red showed a high amount of pectin in the cell wall on day zero as well as its decrease in the wall during ripening and its accumulation in the central area of the cell. Scanning microscopy showed loss of the cell structure during ripening. Those observations suggest that the pectin is the main polymer responsible for firmness maintenance in the guava fruit.

Rôle de l'axe CD40/CD40L dans la régulation de la fonction paquettaire

Le CD40 ligand (CD40L) est une molécule inflammatoire appartenant à la famille du Facteur de Nécrose Tumorale ("Tumor Necrosis Factor", TNF), originalement identifié au niveau des cellules immunitaires. L’interaction du CD40L avec son récepteur de haute affinité présent sur les cellules B, le CD40, est d’une importance cruciale à la production d’immunoglobulines lors de la réponse immunitaire. Aujourd’hui, nous savons que ces deux molécules qui constituent l’axe CD40/CD40L sont aussi exprimées au niveau des cellules du système vasculaire et occupent une place importante dans une variété de réactions inflammatoires, de sorte que le CD40L est présentement reconnu comme une molécule thrombo-inflammatoire prédictive des évènements cardiovasculaires. Les plaquettes sont la principale source du CD40L soluble ("soluble CD40L", sCD40L) plasmatique et il fut démontré être impliqué dans l’activation plaquettaire, malgré que son impact exact sur la fonction plaquettaire et les mécanismes sous-jacents demeurent inconnus. Ainsi, le but de ce projet était de déterminer l’impact du sCD40L sur la fonction plaquettaire et d’élucider les mécanismes cellulaires et moléculaires sous-jacents. Les objectifs spécifiques étaient : 1) d’évaluer l’impact du sCD40L sur l’activation et l’agrégation plaquettaire in vitro; 2) de déterminer le récepteur cible (CD40 ou autre) impliqué dans ces effets; 3) de décortiquer les voies signalétiques intracellulaires et moléculaires induites par le sCD40L, impliquant la participation potentielle de la famille du facteur associé du récepteur du TNF ("Tumor Necrosis Factor Receptor Associated Factor", TRAF) et 4) d’analyser l’effet du sCD40L sur la formation du thrombus in vivo. Le sCD40L augmente fortement l’activation et l’agrégation plaquettaire induite par de faibles doses d’agonistes. Les plaquettes humaines traitées avec une forme mutante du sCD40L qui n’interagit pas avec le CD40 et les plaquettes de souris CD40 déficientes (CD40-/-) ne furent pas en mesure d’induire ces effets. De plus, nous démontrons la présence de plusieurs membres de la famille des TRAFs dans les plaquettes, parmi lesquels seulement TRAF-2 interagit avec le CD40 suite à la stimulation par le sCD40L. Le sCD40L agit sur les plaquettes au repos par l’entremise de la protéine Rac1 et de sa cible en aval, soit la protéine kinase activatrice du mitogène p38 ("Mitogen Activating Protein Kinase", MAPK). Ceci mène ultimement au changement de forme plaquettaire et à la polymérisation de l’actine. Par ailleurs, il est intéressant de noter que les souris CD40-/- démontrent un défaut significatif de l’agrégation plaquettaire en réponse au collagène, ce qui souligne l’importance du CD40 dans les interactions plaquettes-plaquettes. Dans un deuxième temps, le sCD40L amplifie l’agrégation plaquettaire en sang complet, accélère les temps de thrombose in vitro mesurés à l’aide du système PFA-100 et augmente l’adhésion plaquettaire au collagène sous condition de flux, le tout par l’entremise du CD40. Finalement, dans un modèle de thrombose artérielle murin, l’infusion du sCD40L exacerbe la formation du thrombus chez les souris du type sauvage ("Wild Type", WT), mais non chez les souris CD40-/-. Ceci fut en plus associé à une augmentation significative du nombre de leucocytes au sein du thrombus des souris WT traitées à l’aide du sCD40L, tel que démontré par marquage immuno-histologique anti-CD45 et par quantification des coupes artérielles par microscopie optique. En résumé, ce projet identifie une nouvelle voie signalétique, TRAF-2/Rac1/p38 MAPK, en réponse au sCD40L et démontre ses effets sur l’activation et l’agrégation plaquettaire. De manière encore plus importante, nous démontrons pour la première fois la présence d’une corrélation positive entre les niveaux circulants du sCD40L et la thrombose artérielle, tout en soulignant l’importance du CD40 dans ce processus. Ainsi, le sCD40L constitue un activateur important des plaquettes, les prédisposant à une thrombose exacerbée en réponse au dommage vasculaire. Ces résultats peuvent expliquer le lien étroit qui existe entre les niveaux circulants du sCD40L et l’incidence des maladies cardiovasculaires.

CD40 signalling in platelet function

Le CD40 est un membre de la famille des récepteurs du facteur de nécrose tumorale ("Tumour necrosis factor", TNF), initialement identifié sur des cellules de carcinome de la vessie. L'interaction du CD40 avec son ligand (CD40L) est d'une importance cruciale pour le développement des cellules B et de la commutation d'isotype au cours de la réponse immunitaire acquise. L'expression du complexe CD40/CD40L était initialement cru d'être limiter aux cellules du système immunitaire, mais aujourd'hui il est bien connu que ce complexe est également exprimé sur les cellules du système circulatoire et vasculaire, et est impliqué dans diverses réactions inflammatoires; de sorte que le CD40L est maintenant considéré comme une molécule thrombo-inflammatoire prédictive des événements cardiovasculaires. Les plaquettes expriment constitutivement le CD40, alors que le CD40L n'est exprimé que suite à leur l'activation. Il est ensuite clivé en sa forme soluble (sCD40L) qui représente la majorité du sCD40L en circulation. Il fut démontré que le sCD40L influence l'activation plaquettaire mais son effet exact sur la fonction plaquettaire, ainsi que les mécanismes cellulaires et moléculaires sous-jacents à son action demeurent inconnus. Ainsi, ce projet a été entrepris dans le but d’adresser les objectifs spécifiques suivants: 1) évaluer les effets in vitro du sCD40L sur l'activation et l'agrégation plaquettaire; 2) identifier les récepteurs plaquettaires impliqués dans l’action du sCD40L; 3) élucider les voies signalétiques intracellulaires induits par le sCD40L; 4) évaluer les effets du sCD40L sur la formation de thrombus in vivo. Nous avons trouvé que le sCD40L augmente fortement l'activation et l'agrégation des plaquettes en réponse à de faibles concentrations d'agonistes. Les plaquettes humaines traitées avec une forme mutante du sCD40L qui n'interagit pas avec le CD40, et les plaquettes de souris déficientes en CD40 ne furent pas en mesure d'induire de telles réponses, indiquant que le récepteur principal du sCD40L au niveau des plaquettes est le CD40. En plus, nous avons identifié la présence de plusieurs membres de la famille du facteur associé du récepteur du TNF ("TNF receptor-associated factor", TRAF) dans les plaquettes et nous avons montré que seulement le TRAF2 s'associe avec le CD40 suite à la stimulation par le sCD40L. Nos résultats indiquent aussi que le sCD40L agisse sur les plaquettes au repos par l'entremise de deux voies signalétiques distinctes. La première voie implique l'activation de la petite GTPase Rac1 et de sa cible en aval, soit la protéine kinase p38 activée par le mitogène ("p38 mitogen-activated protein kinase", p38 MAPK ), menant au changement de forme plaquettaire et à la polymérisation de l'actine; alors que la deuxième voie implique l'activation de la cascade signalétique du NF-kB. Par ailleurs, à la suite d'une lésion artérielle induite par le chlorure de fer, le sCD40L exacerbe la formation de thrombus et l'infiltration leucocytaire au sein du thrombus dans les souris du type sauvage, mais pas chez les souris déficientes en CD40. En conclusion, ce projet a permis d'identifier pour la première fois deux voies signalétiques distinctes en aval du CD40 plaquettaire et a permis d'établir leur implication dans l'activation et l'agrégation plaquettaire en réponse au sCD40L. De manière plus importante, ce projet nous a permis d'établir un lien direct entre les niveaux élevés du sCD40L circulant et la formation de thrombus in vivo, tout en soulignant l'importance du CD40 dans ce processus. Par conséquent, l'axe CD40/CD40L joue un rôle important dans l'activation des plaquettes, les prédisposant à une thrombose accrue en réponse à une lésion vasculaire. Ces résultats peuvent expliquer en partie la corrélation entre les taux circulants élevés du sCD40L et l'incidence des maladies cardiovasculaires.

Spectrophotometric Methods for the Determination of Cafotaxime Sodium In Dosage Forms

Two simple and sensitive spectrophotometric methods(A and B) in the visible region have been developed for the determination of cefotaxime sodium (DFTS) in bulk and in dosage forms. Method A is based on the reaction of CFTS with nitrous acid under alkaline conditions to form a stable violet colored chromogen with absorption maximum of 560 nm and method B is based on the reaction of CFTS with1,10-phenanthroline and ferric chloride to form a red colored chromogen with the absorption maximum of 520 mm.The color obeyed Beer’s law in the concentration range of 100-500 µg/ml for method A and 1.6-16 µg/ml for method B, respectively.When pharmaceutical preparations containing CFTS were analysed, the results obtained by the proposed methods are in good agreement with the labeled amounts and are comparable with the results obtained using a UV spectrophotometric method.

Estudio preliminar del retardo mental en la población de Rovira (Tolima, Colombia)

El retardo mental se caracteriza por limitaciones en el desempeño como resultado de significativas deficiencias de la inteligencia y la conducta adaptativa. En Colombia, la mayor parte de los pacientes con esta alteración no reciben evaluación genética. El objetivo de este trabajo es evaluar y caracterizar el retardo mental en un grupo de personas con esta condición en la población de Rovira (Tolima, Colombia) e identificar los posibles factores asociados. La metodología consistió en realizar un diagnóstico clínico preliminar de 25 pacientes con retardo mental y realizar la correspondiente toma de muestras de sangre y orina para efectuar los exámenes correspondientes. Se realizaron estudios bioquímicos (cloruro férrico, nitrosonaftol, nitroprusiato de sodio, Benedict, cromatografía para la detección de aminoácidos y carbohidratos) y citogenéticos (bandeo G). Para la detección de plaguicidas, se realizó un muestreo aleatorio en diferentes puntos de todo el recorrido del sistema de distribución de agua y ciertos lugares del centro del municipio de Rovira. Con este fin, se recolectaron 20 muestras de agua y 20 muestras de tomate, elegidas al azar, de los diferentes sitios de distribución y cultivos de la hortaliza. Se identificó una familia de tres hijos afectados (dos mujeres y un hombre) con retardo mental, lo cual sugiere un componente genético en este caso. Las pruebas metabólicas fueron negativas y los cariotipos normales. Se plantea la necesidad de realizar pruebas moleculares que incluyan el síndrome de X-frágil para complementar el estudio y realizar consejería genética. En cuanto a los resultados y el análisis pertinente de las muestras para organofosforados, el 100% de éstas resultaron positivas. Se reportó un 60% de positividad en las muestras de agua y del 100% en las muestras de tomate, para el caso de los carbamatos; sin embargo, para el caso de los organoclorados, el 100% de las muestras estudiadas resultaron negativas.

Platelet PECAM-1 inhibits thrombus formation in vivo

Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a cell surface glycoprotein receptor expressed on a range of blood cells, including platelets, and on vascular endothelial cells. PECAM-1 possesses adhesive and signaling properties, the latter being mediated by immunoreceptor tyrosine-based inhibitory motifs present on the cytoplasmic tail of the protein. Recent studies in vitro have demonstrated that PECAM-1 signaling inhibits the aggregation of platelets. In the present study we have used PECAM-1-deficient mice and radiation chimeras to investigate the function of this receptor in the regulation of thrombus formation. Using intravital microscopy and laser-induced injury to cremaster muscle arterioles, we show that thrombi formed in PECAM-1-deficient mice were larger, formed more rapidly than in control mice, and were more stable. Larger thrombi were also formed in control mice that received transplants of PECAM-1-deficient bone marrow, in comparison to mice that received control transplants. A ferric chloride model of thrombosis was used to investigate thrombus formation in carotid arteries. In PECAM-1-deficient mice the time to 75% vessel occlusion was significantly shorter than in control mice. These data provide evidence for the involvement of platelet PECAM-1 in the negative regulation of thrombus formation.

Antioxidant properties of Teaw (Cratoxylum formosum Dyer) extract in soybean oil and emulsions

The antioxidant activity of an extract from Teaw (Cratoxylum formosum Dyer) leaves was studied in soybean oil and soybean oil-in-water emulsions. Samples containing the extract or reference antioxidants including chlorogenic acid, which comprises 60% of the Teaw extract, were stored at 60 degrees C and analyzed periodically for peroxide value (PV) and thiobarbituric acid reactive substances (TBARS) to allow both hydroperoxides and hydroperoxide degradation products to be monitored. Chlorogenic acid and the Teaw extract were more effective than a-tocopherol in inhibiting lipid oxidation in bulk oil but were less effective in an oil-in-water emulsion in accordance with the polar paradox. The PV/TBARS ratio for oil samples containing chlorogenic acid was higher than for alpha-tocopherol and BHT because chlorogenic acid inhibits both hydroperoxide formation by radical scavenging and hydroperoxide decomposition by metal chelation. The importance of the metal-chelating activity in retarding hydroperoxide decomposition was confirmed by studying the decomposition of oil samples containing added ferric ions. The PV/TBARS ratio was higher for citric acid than for (x-tocopherol in the presence of added ferric chloride, but the order was reversed in samples lacking ferric chloride. Samples containing added chlorogenic acid gave the highest PV/TBARS ratios both in the presence and absence of ferric ions. The PV/TBARS ratios for the samples containing antioxidants fell rapidly to lower values in a soybean oil-in-water emulsion than in the soybean oil. This was due to increased hydroperoxide decomposition in the emulsion at the same PV. The Teaw extract contained 12% oil-soluble components, which contributed to a slightly higher oil-water partition coefficient than that of chlorogenic acid. The antioxidant activity of the aqueous phase of the Teaw extract was reduced more than that of chlorogenic acid by partitioning of the oil-soluble components into oil, which showed that the less-polar components contributed to the antioxidant activity of the Teaw extract in aqueous media.

Efficiency and purity control in the preparation of pure and/or aluminum-doped barium ferrites by hydrothermal methods using ferrous ions as reactants

The synthesis of hexagonal barium ferrite (BaFe12O19) was studied under hydrothermal conditions by a method in which a significant amount of ferrous chloride was introduced along side ferric chloride among the starting materials. Though all of the Fe2+ ions in the starting material were converted to Fe3+ ions in the final product, Fe2+ was confirmed to participate differently from the Fe3+ used in the conventional method in the mechanism of forming barium ferrite. Indeed the efficiency of the synthesis and the quality of the product and the lack of impurities such as Fe2O3 and BaFe2O4 were improved when Fe2+ was included. However, the amount of ferrous ions that could be included to obtain the desired product was limited with an optimum ratio of 2:8 for FeCl2/FeCl3 when only 2h of reaction time were needed. It was also found that the role of trivalent Fe3+ could be successfully replaced by Al3+. Up to 50% of their on could be replaced by Al3+ in the reactants to produce Al- doped products. It was also found that the ratio of Fe2+/M3+ could be increased in the presence of Al3+ to produce high quality barium ferrite.

CLEC-2 is not required for platelet aggregation at arteriolar shear

The C-type lectin receptor CLEC-2 is expressed primarily on the surface of platelets, where it is present as a dimer, and is found at low level on a subpopulation of other hematopoietic cells, including mouse neutrophils [1–4] Clustering of CLEC-2 by the snake venom toxin rhodocytin, specific antibodies or its endogenous ligand, podoplanin, elicits powerful activation of platelets through a pathway that is similar to that used by the collagen receptor glycoprotein VI (GPVI) [4–6]. The cytosolic tail of CLEC-2 contains a conserved YxxL sequence preceded by three upstream acidic amino acid residues, which together form a novel motif known as a hemITAM. Ligand engagement induces tyrosine phosphorylation of the hemITAM sequence providing docking sites for the tandem-SH2 domains of the tyrosine kinase Syk across a CLEC-2 receptor dimer [3]. Tyrosine phosphorylation of Syk by Src family kinases and through autophosphorylation leads to stimulation of a downstream signaling cascade that culminates in activation of phospholipase C γ2 (PLCγ2) [4,6]. Recently, CLEC-2 has been proposed to play a major role in supporting activation of platelets at arteriolar rates of flow [1]. Injection of a CLEC-2 antibody into mice causes a sustained depletion of the C-type lectin receptor from the platelet surface [1]. The CLEC-2-depleted platelets were unresponsive to rhodocytin but underwent normal aggregation and secretion responses after stimulation of other platelet receptors, including GPVI [1]. In contrast, there was a marked decrease in aggregate formation relative to controls when CLEC-2-depleted blood was flowed at arteriolar rates of shear over collagen (1000 s−1 and 1700 s−1) [1]. Furthermore, antibody treatment significantly increased tail bleeding times and mice were unable to occlude their vessels after ferric chloride injury [1]. These data provide evidence for a critical role for CLEC-2 in supporting platelet aggregation at arteriolar rates of flow. The underlying mechanism is unclear as platelets do not express podoplanin, the only known endogenous ligand of CLEC-2. In the present study, we have investigated the role of CLEC-2 in platelet aggregation and thrombus formation using platelets from a novel mutant mouse model that lacks functional CLEC-2.